Therapeutic experience of 289 elderly patients with biliary diseases

doi:10.3748/wjg.v23.i13.2424

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9124)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

856

WORD

469

HTML

5074

Figures (1-4)

174

Tables (1-6)

163

Sum=6736

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

902

Download

1486

Sum=2388

Apr 7, 2017 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Apr 7, 2017; 23(13): 2424-2434
Published online Apr 7, 2017. doi: 10.3748/wjg.v23.i13.2424

Table 5 Comparison of laboratory test results at admission in surgical and non-surgical groups

Item	Surgical group, n = 173	Non-surgical group, n = 116	t	P value
Routine blood
WBC (× 10⁹/L)	8.54 ± 4.77	10.41 ± 5.58	-3.054	0.002^a
N%	71.94 ± 14.81	79.45 ± 13.55	-4.450	0.000^a
Hb (g/L)	127.41 ± 20.44	121.00 ± 20.06	2.631	0.009^a
hs-CRP (mg/L)	50.02 ± 76.60	52.48 ± 58.76	-0.288	0.774
Liver function
ALT (U/L)	70.17 ± 103.96	94.13 ± 139.50	-1.573	0.117
AST (U/L)	71.32 ± 115.81	105.00 ± 190.88	-1.696	0.092
TP (g/L)	62.65 ± 8.33	62.06 ± 8.94	-0.553	0.581
Alb (g/L)	36.59 ± 5.92	35.16 ± 5.75	2.030	0.043^a
TB (μmol/L)	51.74 ± 103.87	34.33 ± 37.06	2.021	0.044^a
DB (μmol/L)	21.99 ± 39.50	15.85 ± 23.37	1.659	0.098
Tumor marker
CA19-9 (U/mL)	340.19 ± 1317.16	896.95 ± 6346.89	-0.880	0.380
CEA (ng/mL)	2.76 ± 4.13	142.66 ± 1283.35	-1.005	0.318
Blood clotting function
APTT (s)	32.49 ± 5.20	32.59 ± 7.56	-0.124	0.901
PT (s)	11.61 ± 1.38	12.12 ± 1.54	-2.739	0.007^a
INR	1.05 ± 0.13	1.09 ± 0.14	-2.318	0.021^a
FIB (g/L)	3.63 ± 1.21	3.69 ± 0.90	-0.449	0.654

^aP < 0.05, surgical group vs non-surgical group. Alb: Albumin; ALT: Alanine aminotransferase; APTT: Activated partial thromboplastin time; AST: Aspartate aminotransferase; CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen; DB: Direct bilirubin; FIB: Fibrin; Hb: Hemoglobin; hs-CRP: High sensitivity C-reactive protein; INR: International normalized ratio; N%: Neutrophil percentage; PT: Prothrombin time; TB: Total bilirubin; TP: Total protein; WBC: White blood cell count.

Citation: Zhang ZM, Liu Z, Liu LM, Zhang C, Yu HW, Wan BJ, Deng H, Zhu MW, Liu ZX, Wei WP, Song MM, Zhao Y. Therapeutic experience of 289 elderly patients with biliary diseases. World J Gastroenterol 2017; 23(13): 2424-2434
URL: https://www.wjgnet.com/1007-9327/full/v23/i13/2424.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i13.2424